When doctors told Katrina Barry that she had a rare and serious condition called pulmonary arterial hypertension or PAH, they warned her not to Google it. Come on, she thought; they wanted a young ...
The new label for Alecensa makes it the first targeted treatment available after surgery for people with ALK-positive lung tumors, who are at high risk for brain metastases.
The health regulor has required related updates to other sections of the label such as warnings and precautions, ...
On Monday, the FDA approved a label expansion for AstraZeneca’s complement inhibitor ravulizumab-cwvz (Ultomiris) for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult ...
The US Food and Drug Administration has approved a fusion protein made by Merck & Co. for a rare, life-threatening lung disorder. The drug, called sotatercept and set to be marketed under the name ...
With the FDA nod, Alecensa becomes the second molecularly targeted therapy to move into the adjuvant setting for non-small cell lung cancer.
When a soldier is rushed to medical care following a blast or other injury to the head, time is crucial in deciding just how extensive that injury is. Now, the U.S. Army has announced that the U.S ...
Duvyzat (givinostat) is histone deacetylase inhibitor that was previously granted priority review, orphan drug designation, and rare pediatric disease designation by the FDA for patients 6 years of ...
(CNN) — When doctors told Katrina Barry that she had a rare and serious condition called pulmonary arterial hypertension or PAH, they warned her not to Google it. Come on, she thought; they ...